- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.52 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Covalent)
- 2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.2: 6 residues within 4Å:- Chain A: L.317, F.494, V.496, E.563, K.566
- Ligands: EDO.24
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.563, A:K.566
- Water bridges: A:R.320, A:S.498
PG4.3: 12 residues within 4Å:- Chain A: F.188, L.190, D.191, L.192, M.194, R.250, A.251, E.459, S.460, N.463, L.534, N.538
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:L.192, A:N.463
- Water bridges: A:L.192, A:M.194, A:R.250, A:N.538
- 1 x K: POTASSIUM ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 5 residues within 4Å:- Chain A: E.277
- Chain C: G.87, D.88, F.98
- Ligands: EDO.21
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: F.232, Y.269, D.330, K.485, Q.488, N.489
Ligand excluded by PLIPEDO.8: 10 residues within 4Å:- Chain A: D.521, W.526, N.527, T.528, D.529
- Chain B: A.39, L.42, L.129, L.132, F.133
Ligand excluded by PLIPEDO.9: 9 residues within 4Å:- Chain A: L.205, I.207, G.210, M.524, V.525, W.526, N.527, L.530, V.531
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: T.316, I.319, L.371, P.372, Q.488
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: R.229, H.238, R.480, E.532
- Chain B: R.46, K.47, A.126
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: K.96, G.97, D.99, N.418, G.558
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: R.88, N.618, A.620, D.621
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: R.229, F.232, G.270, L.481, Q.484
- Chain B: R.125
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: Y.548, A.552, V.605, L.607
- Ligands: EDO.16
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain A: Q.501, C.504, Y.548, E.551
- Ligands: EDO.15
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain A: Y.109, K.386, A.434, L.437, S.438, E.441
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: S.508, Y.548, G.603, K.604, V.605
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain A: N.384, L.390, D.397, Q.398, I.399
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain A: N.86, W.89, F.148
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain A: S.307, R.308
- Ligands: EDO.6
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain A: F.62, R.65
- Chain B: E.44, R.48, N.81
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain A: H.67, G.225, G.226, S.236, S.240, E.408
- Ligands: FAD.1
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain A: Y.298, V.310, R.313, S.314, L.317, E.563
- Ligands: PG4.2
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain A: G.497, Q.501, K.554, R.562, Y.565
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain A: E.440, E.441, S.442, C.443, R.444
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain A: R.43, A.117, E.120, L.121, Y.124, V.429, R.433
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain A: Y.572, Y.574, I.578, P.626, P.627
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain A: R.313, S.556, A.561, R.562, E.563, K.566
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain A: K.615, T.616, L.617, N.618, E.619
Ligand excluded by PLIPEDO.32: 10 residues within 4Å:- Chain A: T.235, G.272, C.273, L.274
- Chain B: L.51, E.52, W.87
- Chain C: R.94, C.95, I.96
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain B: R.125, A.126, P.127, D.128
Ligand excluded by PLIPEDO.34: 5 residues within 4Å:- Chain B: F.60, E.63, H.64, L.110, F.114
Ligand excluded by PLIPEDO.35: 6 residues within 4Å:- Chain A: E.353, M.356, I.357
- Chain B: T.94, E.95, K.116
Ligand excluded by PLIPEDO.37: 6 residues within 4Å:- Chain C: V.68, N.69, P.70, P.78, R.79, G.80
Ligand excluded by PLIP- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.31: 9 residues within 4Å:- Chain A: E.198, C.199, R.200, K.218, N.219, P.401, G.402, C.443, P.450
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:C.199, A:N.219, A:N.219
- Water bridges: A:R.200
PEG.36: 5 residues within 4Å:- Chain B: E.28, E.70, K.71, N.74, L.75
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.70, B:E.70, B:N.74
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sharma, P. et al., Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nat Commun (2024)
- Release Date
- 2024-01-10
- Peptides
- Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial: A
Succinate dehydrogenase assembly factor 2, mitochondrial: B
Succinate dehydrogenase assembly factor 4, mitochondrial: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.52 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Covalent)
- 2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x K: POTASSIUM ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sharma, P. et al., Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nat Commun (2024)
- Release Date
- 2024-01-10
- Peptides
- Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial: A
Succinate dehydrogenase assembly factor 2, mitochondrial: B
Succinate dehydrogenase assembly factor 4, mitochondrial: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C